GlaxoSmithKline in $3 billion fraud settlement

July 2, 2012

GlaxoSmithKline was slapped with a $3 billion fine Monday by the U.S. Justice Department after failing to report safety data on some of the company’s most popular drugs. (CNN)

Posted by

Posted in Biotech, News